首页> 外国专利> TRANSCRIPTION FACTOR-DNA BINDING ASSAY

TRANSCRIPTION FACTOR-DNA BINDING ASSAY

机译:转录因子-DNA结合测定

摘要

Pharmacological agent is identified in high production drug screening measurement, and the diagnosis or treatment to disease associated with the expression of a gene are useful. Method is related to combining the transcription factor of a label, nucleic acid, a candidate pharmacological agent and the receptor for being coupled to a cooperation base, is fixed on a solid substrate, such as a microtiter plate, filter or pearl. Nucleic acid have at least that be related to naturally for sequence specific be with transcription factor interaction required gene transcription management nucleotide sequence part. The combination of synthesis is incubated under situation, therefore receptor is bound to cooperation base, and still for the presence of the candidate pharmacological medicament, transcription factor is the nucleic acid that sequence is specifically bound to. Then cutting transcription factor removes or washes from solid substrate and label, detection sequence-particularly controlled transcription factor. The candidate agent deviation control that it includes the transcription factor for changing binding is incubated to incubate for label signal -- in general, binding division, and signal is reduced. In the preferred embodiment, entire processing is carried out by a computer controlled electric-machine driving machine people with an axial rotatable arm.
机译:在高产量药物筛选测量中鉴定了药理学试剂,并且对与基因表达相关的疾病的诊断或治疗是有用的。该方法涉及将标记的转录因子,核酸,候选药理学试剂和与偶联碱基偶联的受体结合在一起,将其固定在固体基质上,例如微量滴定板,滤膜或珍珠。核酸至少具有天然相关的序列特异性与转录因子相互作用所需的基因转录管理核苷酸序列部分有关。合成的组合在这种情况下被孵育,因此受体被结合到协同碱基上,并且对于候选药理药物的存在,转录因子仍然是序列特异性结合的核酸。然后切割转录因子从固体底物和标记物上去除或洗涤,检测序列特别是受控的转录因子。孵育包含结合改变转录因子的候选药物偏离控制,以孵育标记信号-通常,结合分裂,信号减少。在优选的实施方式中,整个过程由具有轴向可旋转臂的计算机控制的电机驱动机器人执行。

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号